Screening for Low Energy Availability in Male Athletes: Attempted Validation of LEAM-Q
Bronwen Lundy, Monica Klungland Torstveit, Thomas Birkedal Stenqvist, Louise M. Burke, Ina Garthe, Gary Slater et al. · 2022 · 66 citationsRead the paper
A questionnaire-based screening tool for male athletes at risk of low energy availability (LEA) could facilitate both research and clinical practice. The present options rely on proxies for LEA such screening tools for disordered eating, exercise dependence, or those validated in female athlete populations. in which the female-specific sections are excluded. To overcome these limitations and support progress in understanding LEA in males, centres in Australia, Norway, Denmark, and Sweden collaborated to develop a screening tool (LEAM-Q) based on clinical investigations of elite and sub-elite male athletes from multiple countries and ethnicities, and a variety of endurance and weight-sensitive sports. A bank of questions was developed from previously validated questionnaires and expert opinion on various clinical markers of LEA in athletic or eating disorder populations, dizziness, thermoregulation, gastrointestinal symptoms, injury, illness, wellbeing, recovery, sleep and sex drive. The validation process covered reliability, content validity, a multivariate analysis of associations between variable responses and clinical markers, and Receiver Operating Characteristics (ROC) curve analysis of variables, with the inclusion threshold being set at 60% sensitivity. Comparison of the scores of the retained questionnaire variables between subjects classified as cases or controls based on clinical markers of LEA revealed an internal consistency and reliability of 0.71. Scores for sleep and thermoregulation were not associated with any clinical marker and were excluded from any further analysis. Of the remaining variables, dizziness, illness, fatigue, and sex drive had sufficient sensitivity to be retained in the questionnaire, but only low sex drive was able to distinguish between LEA cases and controls and was associated with perturbations in key clinical markers and questionnaire responses. In summary, in this large and international cohort, low sex drive was the most effective self-reported symptom in identifying male athletes requiring further clinical assessment for LEA.
What the full text shows
Working prototype- Low sex drive was the only questionnaire variable capable of distinguishing between LEA cases and controls. (Male elite and sub-elite athletes)
- Athletes with low sex drive showed significantly lower total testosterone, T3, insulin, and femur BMD Z-score compared to those with normal sex drive. — Total testosterone: 18.0±6.0 vs 20.9±5.6 nmol/L; T3: 5.3±0.7 vs 5.6±0.7 pmol/L; Insulin: 21.1±10.3 vs 25.8±9.8 nmol/L; Femur BMD Z-score: -0.02±0.97 vs 0.39±0.88 (Comparison between low and normal sex drive groups)
- Athletes with low sex drive exhibited a higher cortisol:insulin ratio and greater weight flux. — Cortisol:insulin ratio: 26.9±17.4 vs 20.6±10.1; Weight flux: 10.2±5.8 vs 8.1±도8.1 kg (Comparison between low and normal sex drive groups)
- The LEAM-Q demonstrated moderate internal consistency and reliability. — ICC = 0.71 (14-day test-retest in 42 male athletes)
- Prevalence of LEA in the study cohort was identified based on clinical markers. — 32% of participants (85/265) classified as LEA cases (Based on two or more primary indicators or three or more overall indicators)
- Setup
- 405 male elite and sub-elite athletes (18-50 years) from Australia, Norway, Denmark, and Sweden; final clinical analysis included 310 participants.
- How
- Researchers developed the LEAM-Q questionnaire based on expert opinion and existing tools, then validated it using a two-step process: a test-retest for reliability and a clinical verification phase comparing self-reported symptoms against biomarkers (RMR, BMD, blood markers). ROC curve analysis was used to determine the sensitivity of individual variables.
- Limitations
- Most questionnaire variables (dizziness, illness, fatigue) failed to distinguish between LEA cases and controls despite having some sensitivity. · Injury scores showed low sensitivity and no association with BMD in this mixed-sport cohort. · The final validated tool was reduced to only the sex drive section, limiting the breadth of the screening. · Potential for misrepresentation in self-reported dietary and exercise data.
Summarized by Gemma 4 from the open-access full text · 7 Oct 2026. Read it